What do systematic reviews say?

Intervention not reported

• Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 388 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in hospital readmission (0 to 3 months) (low certainty).

• Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes only
  RR 0.89 [0.52, 1.5]
  1 study · 299 participants
  Low

Intervention not reported

• Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 84 participants
  Very low

Intervention not reported

The review found no eligible studies for this question.

• Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

NPWT vs standard dressing

The review found no eligible studies for this question.

• Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

NPWT vs standard dressing

The review found no eligible studies for this question.

• Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

NPWT vs standard dressing

It is very uncertain whether NPWT changes adverse events compared with standard dressings therapy (very low certainty).

• Negative pressure wound therapy for treating pressure ulcers 2023 · Cochrane Headline outcomes only
  RR 1.25 [0.64, 2.44]
  1 study · 12 participants
  Very low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

It is very uncertain whether surfactant treatment guided by rapid tests for surfactant deficiency changes mortality prior to hospital discharge№ of participants: 562 (3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (very low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 1.25 [0.65, 2.41]
  Studies not reported
  Very low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in bronchopulmonary dysplasia№ of participants: 562(3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 0.9 [0.61, 1.32]
  Studies not reported
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in surfactant utilization № of participants: 562 (3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 0.97 [0.85, 1.11]
  Studies not reported
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in any pneumothorax№ of participants: 506(2 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 0.53 [0.15, 1.92]
  Studies not reported
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Combination vs nicotine replacement therapy monotherapy

Combination leads to higher smoking cessation compared with single‐form nicotine replacement therapy (high certainty).

• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
  RR 1.27 [1.17, 1.37]
  16 studies · 12169 participants
  High

Longer vs shorter duration of nicotine patch therapy

• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 7078 participants
  Low

Longer vs shorter duration of nicotine patch therapy

• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 1173 participants
  Very low

Longer vs shorter duration of nicotine patch therapy

• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 648 participants
  Very low

Combination vs nicotine replacement therapy monotherapy

Combination showed no clear difference in overall serious adverse events compared with single‐form nicotine replacement therapy (low certainty).

• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
  RR 4.44 [0.76, 25.85]
  5 studies · 2888 participants
  Low

Combination vs nicotine replacement therapy monotherapy

It is very uncertain whether combination changes treatment withdrawals compared with single‐form nicotine replacement therapy (very low certainty).

• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
  RR 1.12 [0.57, 2.2]
  5 studies · 3070 participants
  Very low